Atrial fibrillation emerged as a frequent and potentially prognostic complication in wild-type transthyretin amyloidosis, ...

A large Framingham Heart Study analysis found that adults with poor cardiovascular health scores on the Life’s Essential 8 ...

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

For people with HIV and atrial fibrillation (Afib or AF), certain oral anticoagulants (OACs) may carry a higher bleeding risk than others, according to a study based on Medicare records. From a ...

They reviewed the case of Dr. G, a 63-year-old man who noticed an irregular heart rate while biking to work and an electrocardiogram confirmed AF. Dr. G has a history of hypertension and ...

Heightened interest in left ventricular thrombus (LVT) stems from the consistent association of subsequent stroke and ...

Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a ...

The use of apixaban for stroke prevention in patients with atrial fibrillation (AF) and liver cirrhosis appears to be safer than other common anticoagulants, a new observational study shows. When ...

Older adults with atrial fibrillation (Afib, or AF), especially those with frailty, had better patient-centered outcomes taking apixaban (Eliquis) than other common oral anticoagulants (OACs ...

Key takeaways: Apixaban tied to less stroke and bleeding in patients with/without dementia vs. dabigatran, rivaroxaban or warfarin. This association was strongest for the outcome of major bleeding.